Recently, we reported that both calcitriol and calcipotriol significantly enhanced the cytotoxicity of an antiangiogenic compound, cediranib, through the upregulation of VEGFR2, at both the protein and mRNA levels, in A375 and SK-MEL-28 melanoma cells [17]. The gene discussed is KDR; the disease is melanoma.